These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21615933)

  • 21. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation.
    Lages CS; Suffia I; Velilla PA; Huang B; Warshaw G; Hildeman DA; Belkaid Y; Chougnet C
    J Immunol; 2008 Aug; 181(3):1835-48. PubMed ID: 18641321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
    Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
    Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node.
    Samy ET; Parker LA; Sharp CP; Tung KS
    J Exp Med; 2005 Sep; 202(6):771-81. PubMed ID: 16172257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.
    Fritzsching B; Oberle N; Pauly E; Geffers R; Buer J; Poschl J; Krammer P; Linderkamp O; Suri-Payer E
    Blood; 2006 Nov; 108(10):3371-8. PubMed ID: 16868256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of regulatory T cell (Treg) subsets in gestational diabetes mellitus.
    Schober L; Radnai D; Spratte J; Kisielewicz A; Schmitt E; Mahnke K; Fluhr H; Uhlmann L; Sohn C; Steinborn A
    Clin Exp Immunol; 2014 Jul; 177(1):76-85. PubMed ID: 24547967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children.
    Freguja R; Gianesin K; Mosconi I; Zanchetta M; Carmona F; Rampon O; Giaquinto C; De Rossi A
    Clin Exp Immunol; 2011 Jun; 164(3):373-80. PubMed ID: 21438872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells.
    Afzali B; Mitchell P; Lechler RI; John S; Lombardi G
    Clin Exp Immunol; 2010 Feb; 159(2):120-30. PubMed ID: 19912251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.
    Burton CT; Westrop SJ; Eccles-James I; Boasso A; Nelson MR; Bower M; Imami N
    Clin Exp Immunol; 2011 Nov; 166(2):191-200. PubMed ID: 21985365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in regulatory T-cells: rediscovered pathways in immunotoxicology.
    Corsini E; Oukka M; Pieters R; Kerkvliet NI; Ponce R; Germolec DR
    J Immunotoxicol; 2011; 8(4):251-7. PubMed ID: 21848365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells.
    Hartigan-O'Connor DJ; Poon C; Sinclair E; McCune JM
    J Immunol Methods; 2007 Jan; 319(1-2):41-52. PubMed ID: 17173927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GARP: a key receptor controlling FOXP3 in human regulatory T cells.
    Probst-Kepper M; Geffers R; Kröger A; Viegas N; Erck C; Hecht HJ; Lünsdorf H; Roubin R; Moharregh-Khiabani D; Wagner K; Ocklenburg F; Jeron A; Garritsen H; Arstila TP; Kekäläinen E; Balling R; Hauser H; Buer J; Weiss S
    J Cell Mol Med; 2009 Sep; 13(9B):3343-57. PubMed ID: 19453521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity.
    Zimmer N; Trzeciak ER; Graefen B; Satoh K; Tuettenberg A
    Front Immunol; 2022; 13():928450. PubMed ID: 35898500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus.
    Loza MJ; Anderson AS; O'Rourke KS; Wood J; Khan IU
    Cell Immunol; 2011; 271(1):110-7. PubMed ID: 21763644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs.
    Steinborn A; Schmitt E; Kisielewicz A; Rechenberg S; Seissler N; Mahnke K; Schaier M; Zeier M; Sohn C
    Clin Exp Immunol; 2012 Jan; 167(1):84-98. PubMed ID: 22132888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
    Fecci PE; Sweeney AE; Grossi PM; Nair SK; Learn CA; Mitchell DA; Cui X; Cummings TJ; Bigner DD; Gilboa E; Sampson JH
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4294-305. PubMed ID: 16857805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
    Elkord E; Abd Al Samid M; Chaudhary B
    Oncotarget; 2015 Aug; 6(24):20026-36. PubMed ID: 26343373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by T
    Nasrallah R; Imianowski CJ; Bossini-Castillo L; Grant FM; Dogan M; Placek L; Kozhaya L; Kuo P; Sadiyah F; Whiteside SK; Mumbach MR; Glinos D; Vardaka P; Whyte CE; Lozano T; Fujita T; Fujii H; Liston A; Andrews S; Cozzani A; Yang J; Mitra S; Lugli E; Chang HY; Unutmaz D; Trynka G; Roychoudhuri R
    Nature; 2020 Jul; 583(7816):447-452. PubMed ID: 32499651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo.
    Zhou AX; Kozhaya L; Fujii H; Unutmaz D
    J Immunol; 2013 May; 190(10):5057-64. PubMed ID: 23576681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia.
    Biancotto A; Dagur PK; Fuchs JC; Wiestner A; Bagwell CB; McCoy JP
    Mod Pathol; 2012 Feb; 25(2):246-59. PubMed ID: 22101351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.